Akili Interactive, a digital therapeutics company in the healthcare technology industry, laid off approximately 30% of its workforce, affecting around 40 employees, as part of a strategic restructuring to extend its financial runway and focus resources on commercializing its over-the-counter product, EndeavorOTC™. The layoffs, announced in early 2024, were driven by the need to reduce operational costs amid challenging market conditions, allowing the company to prioritize key growth initiatives in cognitive medicine.
